Check out your Company Bowl for anonymous work chats.
Join 23andMe in our mission to be the world’s trusted source of personal genetic information. Our Product R&D team is seeking an outstanding Bioinformatics Data Scientist who wants to challenge and push the boundaries of technology and science. This is a unique opportunity to help people benefit from the human genome! As a Bioinformatics Data Scientist on our Genetics Platform Analytics Team, your work will help improve and monitor the data quality of 23andMe’s genotyping platform.
In honor of #WomensEqualityDay last Friday, our women’s employee resource group 23andShe hosted an employee panel with Maya Lowe, Ayanna Ajilore, Kim Noel, Jennifer Low and Stella Aslibekyan, moderated by Sarah Woods-Killam and Sophia Majeed. During the event, they discussed what equality means to them, recalled the first time they were discriminated against and dove into what allies can do to support women. The event ended with the panelists providing advice and tips for women, all of which centered around taking care of yourself, finding a community for support and remembering that your voice and feelings matter.
Last week we hosted a panel with 23andMe customers Bradley, Amy, Walt and Stacy, moderated by 23andMe’s Lindsay Rickling. The customers all found out they were donor-conceived after testing with 23andMe and shared their unique stories and experiences. It was a great opportunity for 23andMe employees to hear from the customers we are helping.
This month we launched our Rare Disease Research Study with the hope that this work may lead to discoveries and insights into possible new treatments. “We have the potential of making genetic findings for several rare diseases for which there currently is very little known,” said John Matthews, Ph.D., M.D., and the Senior Clinical Development Leader on 23andMe’s Therapeutics team.
As the Pharmacist in charge at the Lemonaid Community Pharmacy, an affiliated entity of 23andMe, Clayton Maxfield assesses medication regimens and dispenses medication to patients. He also administers vaccines, performs COVID-19 testing and runs several point of care tests for blood sugar, cholesterol and hemoglobin A1c. When asked what his favorite part about working at 23andMe is, Clayton said, “The company culture and atmosphere. The core values supported by the company and the way that they treat and respect their employees is unlike any other company that I have ever been a part of and I really take notice of that.” Outside of work, Clayton enjoys being active, traveling, and trying new cuisine. He most recently traveled to Jamaica and discovered Jamaican beef patties and traditional jerk chicken.
An extensive new genetic study identified 289 genes involved with insomnia. This study almost doubled the size of the previous largest genome-wide association study on insomnia. And it helps us explore some of the genes associated with insomnia that appeared linked to metabolic or psychiatric conditions. Read more in our blog.
Adrianne Nina, host of the Good Risings podcast Level-Up Latte, explores her personal growth over the past year since receiving her 23andMe reports. Listen to this episode of Spit, an iHeartRadio podcast with 23andMe, here: https://lnkd.in/d-d6bQq7
In just 18 months, we’ve met our goal of recruiting more than 1,500 individuals with systemic sclerosis to participate in groundbreaking genetic research. Thanks to 23andMe systemic sclerosis study participants who consented to participate in research, we advance closer to unlocking valuable genetic insights into this rare autoimmune disease.
To offer richer and more detailed information for people with Chinese ancestry, we recently added three new Chinese populations to our ancestry breakdown. With more than 30 detailed ancestry regions in China and 19 in Taiwan, 23andMe was already the best DNA test for people with Chinese ancestry, but in our commitment to making a product that is more equitable for all and better represents the genetic diversity of the world, we will always be looking for ways to improve.
A promising new genetic study looked at the data of about 5,700 individuals with Parkinson’s disease. The findings may help those looking for ways to avert some of the troubling side effects of a common medication used to treat Parkinson’s disease.
